Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Discovery of a novel, orally available, transient receptor potential channel 6 inhibitor

Aug. 28, 2018

Cathepsin S inhibitors discovered at Astellas

Aug. 23, 2018

GNE-684: a potent inhibitor of RIPK1 for treating inflammatory diseases due to dysregulated NEMO

Aug. 22, 2018

Principia Biopharma patents proteasome subunit beta type-8/beta type-9 inhibitors

Aug. 17, 2018

MAP3K5 inhibitors identified by Fujian Cosunter Pharmaceutical Co., Medshine Discovery

Aug. 13, 2018

Uncovering the function of Cep57 in mosaic-variegated aneuploidy syndrome

Aug. 13, 2018

BRD4 inhibitors patented by Luoxin Biotechnology Shanghai, Shandong Luoxin Pharmacy Group

July 30, 2018

Vasopressin inhibition decreases mortality in jet-lagged mice

July 24, 2018

Fixing nuclear transport helps cells cope with premature, normal aging

July 11, 2018

Celtaxsys divulges new LTA-4 hydrolase inhibitors

July 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...